Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis
DJW den Braanker, RJ Maas… - Nephrology Dialysis …, 2021 - academic.oup.com
DJW den Braanker, RJ Maas, JK Deegens, C Yanginlar, JFM Wetzels, J van der Vlag…
Nephrology Dialysis Transplantation, 2021•academic.oup.comBackground Many patients with idiopathic focal segmental glomerulosclerosis (FSGS)
develop recurrence of proteinuria after kidney transplantation (TX). Although several
circulating permeability factors (CPFs) responsible for recurrence have been suggested,
there is no consensus. To facilitate CPF identification and predict recurrence after TX, there
is a need for robust methods that demonstrate the presence of CPFs. Methods Cultured
human podocytes (hPods) and human and mouse glomerular endothelial cells (ciGEnC …
develop recurrence of proteinuria after kidney transplantation (TX). Although several
circulating permeability factors (CPFs) responsible for recurrence have been suggested,
there is no consensus. To facilitate CPF identification and predict recurrence after TX, there
is a need for robust methods that demonstrate the presence of CPFs. Methods Cultured
human podocytes (hPods) and human and mouse glomerular endothelial cells (ciGEnC …
Background
Many patients with idiopathic focal segmental glomerulosclerosis (FSGS) develop recurrence of proteinuria after kidney transplantation (TX). Although several circulating permeability factors (CPFs) responsible for recurrence have been suggested, there is no consensus. To facilitate CPF identification and predict recurrence after TX, there is a need for robust methods that demonstrate the presence of CPFs.
Methods
Cultured human podocytes (hPods) and human and mouse glomerular endothelial cells (ciGEnC, mGEnC) were exposed to plasmas of FSGS patients with presumed CPFs, and of (disease) controls. A visual scoring assay and flow cytometry analysis of side scatter were used to measured changes in cellular granularity after exposure to plasma.
Results
Nine out of 13 active disease plasmas of 10 FSGS patients with presumed CPFs induced granularity in hPod in a dose- and time-dependent manner. Corresponding remission plasmas induced no or less granularity in hPod. Similar results were obtained with ciGEnC and mGEnC, although induced granularity was less compared with hPod. Notably, foetal calf serum, healthy plasma and a remission plasma partially blocked FSGS plasma-induced hPod granularity.
Conclusions
We developed a novel assay in which active disease, presumably CPF-containing, FSGS plasmas induced granularity in cultured hPod. Our results may indicate the presence of CPF inhibitor(s) in healthy and remission plasma. We suggest the presence of a delicate balance between CPF and a CPF inhibitory factor, which is disturbed in patients with active disease. Our novel assays can be applied in future research to identify CPF and CPF inhibitors, and possibly to predict recurrence after TX.
Oxford University Press以上显示的是最相近的搜索结果。 查看全部搜索结果